The Physician Scientist call offers 10 fully-funded positions.
This is the list of the available laboratories among the top-tier labs funded by the AIRC "Investigator Grant", offering a project.
In the application form, the applicants will be required to indicate the research area/s of interest, and the laboratory/ies in which they would like to conduct their research.
Surname & Name | Research Center/University | Research Area | Title of the project | Description |
---|---|---|---|---|
Amati Bruno | European Institute of Oncology | Molecular Therapy | Exploiting synthetic-lethality toward targeted therapeutic development against MYC/BCL2-driven B-cell lymphoma | More Info |
Bardelli Alberto | University of Turin | Genomic Medicine | Targeting Metastatic Prowess with Translational Oncology | More Info |
Bonecchi Raffaella | Humanitas University | Immunology | Impact of IDH Mutation on immune dynamics in gliomas | More Info |
Campaner Stefano | University of Padua | Cancer Biology | Targeting Transcription Replication Pathways in Tumors | More Info |
Cea Michele | University of Genua | Cancer Biology | Targeting Metabolic Reprogramming to Improve Therapeutic Outcomes in Multiple Myeloma | More Info |
Cosentino Lagomarsino Marco | IFOM ETS - The AIRC Institute of Molecular Oncology | Computational biology | Characterization of persister cell population dynamics through high-content methods | More Info |
Costanzo Vincenzo | IFOM ETS - The AIRC Institute of Molecular Oncology | Cancer Biology | Replication-stress-driven placental-like programme and immune escape in aggressive human cancers | More Info |
Damia Giovanna | Mario Negri Institute | Molecular Therapy | Overcoming poly-ADP-rybose-polymerase inhibitor resistance in ovarian carcinoma | More Info |
De Cecco Loris | Mario Negri Institute | Computational biology | Spatial Metagenomic and Tumor Microenvironment landscape in Head and Neck Cancer for AI-Driven Immunotherapy Prediction | More Info |
Di Tommaso Luca | Humanitas University | Molecular Therapy | Dissecting the transcriptomic profile of endothelial cells (EC) in VETC+ cancers pave the way to a true personalized medicine | More Info |
D'Incalci Maurizio | Humanitas Mirasole | Genomic Medicine | Analysis of DNA from cervical swabs for early detection of ovarian and p53-abnormal endometrial cancers | More Info |
Elisei Rossella | University of Pisa | Cancer Biology | Genetic hallmarks of invasive and non-invasive medullary thyroid cancer | More Info |
Ficara Francesca | Humanitas Mirasole | Cancer Biology | Targeting PBX as a novel therapy for myeloproliferative neoplasm: effect on disease course through innovative assays | More Info |
Lugli Enrico | Humanitas Mirasole | Immunology | Biomarkers of anti-tumor response in solid tumors treated with combination immunotherapy targeting immunosuppression | More Info |
Marcenaro Emanuela | University of Genua | Immunology | Decoding Natural Killer Cell Function in the Tumor Microenvironment of Women’s Cancers: from Bench to Bedside | More Info |
Mavilio Domenico | University of Milan | Immunology | Targeting tumor immune-evasion mechanisms to limit the metastatic progression of human colorectal cancer to liver | More Info |
Mazzucchelli Serena | University of Milan | Molecular Therapy | Exploitation of Indocyanine green loaded engineered protein nanocages for photodynamic therapy of Breast Cancer | More Info |
Morandi Andrea | University of Florence | Cancer Biology | Investigating the role of peroxisomes in modulating radiotherapy response in breast cancer | More Info |
Pelicci Pier Giuseppe | European Institute of Oncology | Cancer Biology | Dissecting and Targeting IFI6-Driven Chemoresistance in Acute Myeloid Leukemia (AML) | More Info |
Polo Simona | IFOM ETS - The AIRC Institute of Molecular Oncology | Cancer Biology | Decoding Early Metastasis in Colorectal Cancer: The Hidden Role of Alternative Splicing | More Info |
Roti Giovanni | University of Parma | Genomic Medicine | Dissecting ETP-ALL Vulnerabilities Via Single-Cell Genomics and Ex Vivo Drug Response Profiling | More Info |
Ruggeri Loredana | Perugia Hospital | Immunology | How to reduce the incidence of acute GvHD and leukemia relapse after HSCT with Treg/Tcon adoptive immunotherapy | More Info |
Santaguida Stefano | European Institute of Oncology | Cancer Biology | Molecular and clinical characterization of micronuclei in chromosomally-unstable tumors | More Info |
Tamagnone Luca | Catholic University of the Sacred Heart | Cancer Biology | Novel molecular mechanisms controlling metastatic ovarian cancer cells | More Info |
Zucali Paolo Andrea | Humanitas Mirasole | Cancer Biology | Targeting pathogenesis and therapies of Thymic Epithelial Tumors at crossroad between cancer immunology and autoimmunity | More Info |